- Conditions
- Prostate Cancer
- Interventions
- Veteran Peer Decision Coaching Session for PSA Screening
- Behavioral
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 40 Years to 69 Years · Male only
- Enrollment
- 228 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2027 – 2028
- U.S. locations
- 1
- States / cities
- New York, New York
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
- Conditions
- Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
- Interventions
- Changes in CRC screening awareness and intentions
- Behavioral
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 25 Years to 75 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Covid19 Pneumonia
- Interventions
- EC-18, Placebo
- Drug
- Lead sponsor
- Enzychem Lifesciences Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 2
- States / cities
- The Bronx, New York • Warwick, Rhode Island
- Conditions
- Coronary Artery Disease, Coronary Stent Occlusion
- Interventions
- Prolonged inflation, Rapid inflation
- Other
- Lead sponsor
- Central Arkansas Veterans Healthcare System
- Federal
- Eligibility
- 19 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2028
- U.S. locations
- 1
- States / cities
- Little Rock, Arkansas
- Conditions
- Alzheimer Disease and Related Dementias, Alzheimer's Disease and Related Dementias
- Interventions
- Smart Environmental Light (SmartEnLite)
- Device
- Lead sponsor
- Penn State University
- Other
- Eligibility
- 55 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- University Park, Pennsylvania
- Conditions
- Mild Cognitive Impairment (MCI)
- Interventions
- Tadalafil 5 mg
- Drug
- Lead sponsor
- Los Angeles Brain Science Project
- Other
- Eligibility
- 60 Years to 90 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Santa Monica, California
- Conditions
- Prostate Cancer
- Interventions
- Clomiphene Citrate 25mg
- Drug
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 19 Years and older · Male only
- Enrollment
- 83 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2037
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska
- Conditions
- CLN3
- Interventions
- Miglustat oral liquid formulation (250 mg/mL)
- Drug
- Lead sponsor
- Beyond Batten Disease Foundation
- Other
- Eligibility
- 4 Years to 17 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 3
- States / cities
- Aurora, Colorado • Baltimore, Maryland • Houston, Texas
- Conditions
- Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts
- Interventions
- VP-102
- Combination Product
- Lead sponsor
- Verrica Pharmaceuticals Inc.
- Industry
- Eligibility
- 2 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 4
- States / cities
- Bowling Green, Kentucky • Owensboro, Kentucky • New York, New York + 1 more
- Conditions
- Diabetes Mellitus, Type 2, Obesity, Overweight
- Interventions
- LY4167586, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 617 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 11
- States / cities
- Anaheim, California • Los Alamitos, California • Walnut Creek, California + 8 more
- Conditions
- Neuropathic Pain
- Interventions
- Multiple-pulse BreEStim Treatment, Single-pulse BreEStim Treatment
- Device
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Hypovitaminosis D
- Interventions
- Vitamin D3, Calcium, and Vitamin C
- Dietary Supplement
- Lead sponsor
- Atlantic Health System
- Other
- Eligibility
- 6 Years to 21 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2027 – 2032
- U.S. locations
- 1
- States / cities
- Morristown, New Jersey
- Conditions
- Children With Medical Complexity (CMC), Family Caregivers
- Interventions
- MAPS (Meaning And Problem Solving), Usual Psychosocial Care
- Behavioral
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2029
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Cubital Tunnel Syndrome
- Interventions
- Conservative Arm, Cubital tunnel release
- Procedure
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 7
- States / cities
- Bethel Park, Pennsylvania • Cranberry Township, Pennsylvania • Monroeville, Pennsylvania + 1 more
- Conditions
- Advanced Cancer, Cancer, Pain
- Interventions
- Cancer Pain 101
- Behavioral
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Alcohol
- Interventions
- Alcohol Cancer Warning Labels
- Behavioral
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Peri-implant Bone and Soft Tissues
- Interventions
- Mixed bone augmentation, Sandwich bone augmentation
- Procedure
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Alcohol Drinking, Breast Cancer
- Interventions
- Sobriety Digital Intervention
- Behavioral
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Suicide
- Interventions
- Center Care as Usual, Toward Hope, Recovery, Interpersonal Growth, Values, and Engagement (THRIVE)
- Behavioral
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 552 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 3
- States / cities
- Huntsville, Alabama • Phoenix, Arizona • Nashville, Tennessee
- Conditions
- Conditions Influencing Health Status, Health-Related Social Needs, Navigation, Social Determinants of Health (SDOH), Social Needs, Social Needs Status
- Interventions
- Active Assistance by Navigators, Passive Referral
- Other
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- Not listed
- Enrollment
- 1,880 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 6
- States / cities
- Oakland, California • San Francisco, California • Philadelphia, Pennsylvania + 1 more
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Intravenous immunoglobulin, Rituximab, Therapeutic Plasma Exchange, Treatment as Usual
- Drug · Other
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 9
- States / cities
- Birmingham, Alabama • Chicago, Illinois • Kansas City, Kansas + 4 more
- Conditions
- Anterior Cruciate Ligament Reconstruction Rehabilitation, Dry Needling, Strength
- Interventions
- Dry Needling
- Procedure
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Other
- Eligibility
- 10 Years to 20 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 3
- States / cities
- Kansas City, Kansas • Overland Park, Kansas • Kansas City, Missouri
- Conditions
- Breast Cancer
- Interventions
- Mini rTG OMEGA-3 Fish Oil
- Drug
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Glioblastoma, IDH-wildtype
- Interventions
- Cemiplimab, Chemotherapy, NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy
- Drug · Device
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 99 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2032
- U.S. locations
- 2
- States / cities
- Rochester, Minnesota • St Louis, Missouri